Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KORU Medical Systems, Inc. Director's Dealing 2016

Mar 2, 2016

33778_dirs_2016-03-02_f8005d71-e9be-45bb-9e79-c5b877185ce1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPRO MED SYSTEMS INC (REPR)
CIK: 0000704440
Period of Report: 2016-02-29

Reporting Person: Narishkin Cyril Nicholas (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-29 Common Stock P 81976 Acquired 81976 Direct
2016-02-29 Common Stock A 14566 Acquired 96542 Direct

Footnotes

F1: Shares issued pursuant to a consulting agreement between the Company and Mr. Narishkin in his capacity as interim COO pursuant to which a portion of Mr. Narishkin's compensation is paid in shares of the Company's common stock. In accordance with the consulting arrangement, the number of shares issued was calculated based on the closing share prices of the Company's common stock on the dates as follows: 10/31/15 at $0.41, 11/30/15 at $0.41, 12/31/15 at $0.55, 1/29/16 at $0.47, 2/9/16 at $0.45.